Evidence Synthesis
HANMAN's quarterly performance showed a shift in its financial health, with the company's gross margin accelerating to 21.95% up from -190.18%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 04:03
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
HANMAN's quarterly performance showed a shift in its financial health, with the company's gross margin accelerating to 21.95% up from -190.18%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 21.95 % | -190.18 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -190.18 % | -49.86 | ▼ |
| REVENUE_GROWTH_YOY | 260.7 % | — | - |
| PRICE_CHANGE_PERCENT | -5.836 % | — | - |
| DAILY_VOLUME | 8,400 shares | 5,250 | ▲ |
| CLOSE_PRICE | 3.55 INR | 3.77 | ▼ |